-
Thailand accuses Cambodia of 'flagrant violation' of truce
-
'Marathon at F1 speed': China bids to lap US in AI leadership
-
Stablecoins inspire hope, and hype, in Hong Kong
-
Markets mixed as China-US talks end, eyes on tech earnings
-
Huge quake off Russia sparks Pacific tsunami warnings
-
Top seed Gauff outlasts Collins to advance at Montreal
-
Ukraine says Russian strike on training camp kills 3 soldiers
-
Trump's MAGA base defies conservative pro-Israel doctrine
-
US Fed set to hold firm against Trump pressure
-
Five products to be hit by Trump's incoming tariffs
-
US second quarter GDP growth to reflect tariff turbulence
-
US, India to launch powerful Earth-monitoring satellite
-
Australia to ban under-16s from YouTube
-
England and India fight fatigue as gripping Test series goes to the wire
-
American Eagle 'jeans' campaign that stars Sydney Sweeney under fire
-
Portugal battles to contain wildfires
-
FIFA World Cup draw in Vegas on December 5: reports
-
Japanese qualifier Ito ousts seventh seed Paolini in Montreal
-
New Athletic captain Williams 'lucky' to represent migrants in Spain
-
Musetti, Rune set winning pace for ATP seeds in Toronto
-
Venus Williams gets US Open mixed doubles wild card spot
-
Tens of thousands of Catholics head to Vatican's Jubilee of Youth
-
Trump says fell out with Epstein because he was taking Mar-a-Lago spa staff
-
Russia strikes kill 25 in Ukraine as Trump shortens Moscow deadline
-
US pushes to revoke scientific ruling that underpins climate regulations
-
US says Trump has 'final call' on China trade truce
-
Goalkeeper Trafford returns to Man City from Burnley
-
Qatar, Saudi, Egypt join call for Hamas to disarm, give up Gaza rule
-
Trump opens Scottish golf course and vows 'peaceful world'
-
Aubameyang close to Marseille return: club
-
Gucci owner Kering posts 46% profit slump before new CEO arrives
-
Cambodia-Thailand truce broadly holds despite shaky start
-
P&G estimates $1 bn tariff hit, plans some US price hikes
-
Wiebes claims Tour de France stage as Vos holds lead
-
Mbeumo looks forward to Fernandes link-up at Man Utd
-
Displaced Cambodians return home after Thailand truce
-
Tens of thousands in Rome for Vatican's Jubilee of Youth
-
Pogacar to skip Vuelta after Tour de France triumph
-
New York mass shooter blamed NFL for his brain injuries
-
Impressive Scandinavia delivers O'Brien Goodwood Cup 1-2
-
US to overturn foundational climate ruling on Tuesday
-
Russia strikes kill 25 in Ukraine as Kremlin notes new Trump deadline
-
Boeing reports smaller loss, sees more 'stability' in operations
-
Jeep owner Stellantis says has turned corner on sales
-
India coach Gambhir clashes with Oval staff ahead of final Test
-
Netherlands bars two hardline Israeli ministers
-
IMF lifts 2025 growth forecast on 'fragile' easing in trade tensions
-
Portugal's Joao Felix joins Ronaldo at Al Nassr in Saudi
-
Ledecky wins 22nd world title as Popovici savours 'scary' gold
-
Stock markets rise as attention shifts from trade deals to company results
RBGPF | -4.75% | 74.03 | $ | |
CMSC | 0.49% | 22.61 | $ | |
SCU | 0% | 12.72 | $ | |
SCS | -3.24% | 10.51 | $ | |
VOD | -0.45% | 11.11 | $ | |
RYCEF | 2.59% | 13.5 | $ | |
RIO | 0.13% | 62.27 | $ | |
NGG | 0.28% | 70.52 | $ | |
RELX | 0.29% | 51.92 | $ | |
GSK | 0.58% | 37.67 | $ | |
BTI | 1.88% | 52.77 | $ | |
CMSD | 0.95% | 23.12 | $ | |
AZN | 2.91% | 73.98 | $ | |
JRI | 0.23% | 13.06 | $ | |
BCC | -0.7% | 86.14 | $ | |
BCE | -0.72% | 23.66 | $ | |
BP | 0.88% | 32.96 | $ |
RFK Jr ousts entire US vaccine panel over alleged conflicts
US Health Secretary Robert F. Kennedy Jr. on Monday announced he was dismissing all members of a key federal vaccine advisory panel, accusing them of conflicts of interest -- his latest salvo against the nation's immunization policies.
The removal of all 17 experts of the Advisory Committee on Immunization Practices (ACIP) was revealed in a Wall Street Journal op-ed and an official press release.
Kennedy, who has spent two decades promoting vaccine misinformation, cast the move as essential to restoring public trust, claiming the committee had been compromised by financial ties to pharmaceutical companies.
"Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," he said in a statement from the Department of Health and Human Services.
"The public must know that unbiased science -- evaluated through a transparent process and insulated from conflicts of interest — guides the recommendations of our health agencies."
In his op-ed, Kennedy claimed the panel was "plagued with persistent conflicts of interest" and had become "little more than a rubber stamp for any vaccine."
He added that new members were being considered to replace those ousted -- all of whom were appointed under former president Joe Biden.
ACIP members are typically chosen for their recognized expertise and are required to disclose potential conflicts of interest.
The decision was met with alarm by Paul Offit, a pediatrician and leading expert on virology and immunology who served on the panel from 1998 to 2003.
"He believes that anybody who speaks well of vaccines, or recommends vaccines, must be deeply in the pocket of industry," Offit told AFP. "He's fixing a problem that doesn't exist."
Once a celebrated environmental lawyer, Kennedy pivoted from the mid-2000s to public health -- chairing a nonprofit that discouraged routine childhood immunizations and amplified false claims, including the long-debunked theory that the Measles, Mumps and Rubella (MMR) vaccine causes autism.
Since taking office, he has curtailed access to Covid-19 shots and continued to raise fears around the MMR vaccine -- even as the United States faces its worst measles outbreak in years, with three reported deaths and more than 1,100 confirmed cases.
Experts warn the true case count is likely far higher.
"How can this country have confidence that the people RFK Jr. wants on the Advisory Committee for Immunization Practices are people we can trust?" Offit asked.
He recalled that during US President Donald Trump's first term, several states formed independent vaccine advisory panels after the administration pressured federal health agencies to prematurely approve Covid-19 vaccines ahead of the 2020 election.
That kind of fragmentation, Offit warned, could happen again.
ACIP is scheduled to hold its next meeting at the headquarters of the Centers for Disease Control and Prevention in Atlanta from June 25 to June 27.
Vaccines for anthrax, Covid-19, human papillomavirus, influenza, Lyme disease, respiratory syncytial virus, and more are on the agenda.
P.Vogel--VB